Correspondence 0001493152-22-032560 from SYNTEC OPTICS HOLDINGS, INC. (OPTX)
SYNTEC OPTICS HOLDINGS, INC.
Date: Nov. 15, 2022 · CIK: 0001866816 · Accession: 0001493152-22-032560
AI Filing Summary & Sentiment
File numbers found in text: 001-41034
Show Raw Text
CORRESP
1
filename1.htm
OmniLit
Acquisition Corp.
1111 Lincoln Road, Suite 500
Miami Beach, FL 33139
(786)
750-2820
Date:
November 15, 2022
VIA
EDGAR
Office
of Real Estate & Construction
Division
of Corporation Finance
U.S.
Securities and Exchange Commission
100
F Street, NE
Washington,
D.C. 20549
Attention:
Melanie
Singh
Maryse
Mills-Apenteng
Re:
OmniLit
Acquisition Corp.
Preliminary
Proxy Statement on Schedule 14A
Filed
November 9, 2022
File
No. 001-41034
Ladies & Gentlemen:
This
letter is in response to the comments of the Staff of the Division of Corporation Finance (the “Staff”) of the U.S. Securities
and Exchange Commission with respect to the above-referenced filing of OmniLit Acquisition Corp. (the “OmniLit”) set forth
in your letter, November 15, 2022.
In
order to facilitate your review of our response, we have restated the Staff’s comments in this letter. For your convenience, we
have also set forth our response to the Staff’s comment immediately below the corresponding comment.
Preliminary
Proxy Statement on Schedule 14A submitted November 9, 2022
Staff
Comment: With a view toward disclosure, please tell us whether your sponsor is, is controlled by, or has substantial ties with a
non-U.S. person. If so, also include risk factor disclosure that addresses how this fact could impact your ability to complete your initial
business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination
with a U.S. target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign
Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which
you could complete an initial business combination may be limited. Further, disclose that the time necessary for government review of
the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require
you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target
company, any price appreciation in the combined company, and the warrants, which would expire worthless.
Response:
OmniLit acknowledges the Staff comments and hereby represent to the staff that OmniLit’s sponsor is not a non-U.S. person,
is not controlled by a non-U.S. person, and does not have substantial ties with a non-U.S. person. Furthermore, we are of the view that
insofar as OmniLit’s sponsor is not a non-U.S. person, is not controlled by a non-U.S. person, and does not have substantial ties
with a non-U.S. person, the risks referred to in the staff’s comment do not represent material risks to the registrant or its shareholders,
and as a result no additional risk disclosure needs to be added to the definitive proxy materials.
We
hope that the foregoing has been responsive to the Staff’s comments. OmniLit needs to proceed with the filing and mailing of definitive
proxy materials as soon as possible. We would greatly appreciate anything you can do to expedite your review. If you have any questions
regarding this matter, please do not hesitate to contact Christopher J. Capuzzi at Ropes & Gray LLP at (212) 596 9575.
Sincerely.
/s/ Al Kapoor
Name:
Al
Kapoor
Title:
Chief
Executive Officer